Catalyst Wire Dossier

Diseases Search Methodology Pricing Log in Sign up free

Diseases · Seborrheic Dermatitis

Seborrheic Dermatitis

📧 Sign up to get email alerts when something new happens for Seborrheic Dermatitis.

Top drugs studied for this disease

Ketoconazole (6)
CLOBETASOL PROPIONATE (5)
ARQ-154 Foam (2)
DERMOTIC (2)
Roflumilast (ARQ-154) Foam 0.3% (1)
Azelaic acid 15% gel (1)
Extina (1)
SEBORRHEAMEDIS Face Cream (1)
Omiganan (1)
PAC-14028 cream (1)

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

No documents found for this filter.

Catalyst Wire Dossier

FDA, ClinicalTrials.gov, and EMA — organized by disease, AI-summarized. Daily updates.

Catalyst Wire family

Dossier SEC FDA Frontier Briefing

Stay updated

Website

Daily FDA actions. One-time €1 verification charge; no recurring payment. Confirm by email, unsubscribe anytime.

Data: openFDA, ClinicalTrials.gov, EMA. Analysis by GPT-5-nano. Not medical advice. · Methodology · Privacy · Terms